Skip to main content
S.M.A.I.O logo

S.M.A.I.O — Investor Relations & Filings

Ticker · ALSMA ISIN · FR0014005I80 LEI · 969500T1Z0DAZXPZMC93 PA Manufacturing
Open in API
Filings indexed 114 across all filing types
Latest filing 2024-08-01 Declaration of Voting R…
Country FR France
Listing PA ALSMA

About S.M.A.I.O

https://smaio.com/

S.M.A.I.O. (Software, Machines and Adaptative Implants in Orthopaedics) is a medical device manufacturer that develops solutions for spine surgery. The company provides a comprehensive platform, I-Kontrol, which incorporates planning software, adaptive implants, and related services for spine surgeons. This integrated solution is designed to enhance control over surgical procedures to improve safety, performance, and repeatability. The I-Kontrol platform covers the entire surgical workflow, including pre-operative planning (i-PLAN), surgical execution with implants (i-PERFORM), post-operative outcome analysis (i-CHECK), and training programs (i-LEARN). S.M.A.I.O. utilizes clinical data, imaging, and artificial intelligence to advance the treatment of vertebral conditions.

Recent filings

Filing Released Lang Actions
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL" (Monthly information relating to the total number of shares and voting rights comprising the share capital). It explicitly references French regulatory articles (Code de Commerce and AMF regulation) and provides a monthly update for 'Juillet 2024' detailing the total number of shares and voting rights. This type of mandatory periodic disclosure regarding the capital structure and voting rights is a specific regulatory filing, but it does not fit perfectly into the provided definitions for 10-K, IR, ER, or DIV. It is a specific regulatory disclosure concerning the capital structure. Given the options, it is closest to a general regulatory filing or a specific capital/share structure update. Since it details the total number of shares and voting rights, it relates directly to the capital structure. However, it is not a 'Share Issue/Capital Change' (SHA) which usually implies an action taken (like a split or new issuance), nor is it a 'Director's Dealing' (DIRS) or 'Major Shareholding Notification' (MRQ). It is a mandatory monthly disclosure of the current capital base. In the context of the provided definitions, this type of mandatory capital structure disclosure, which is not a dividend, share issue, or insider trade, is best categorized as a general Regulatory Filing (RNS) or potentially a very specific type of Capital/Financing Update (CAP) if the intent is to track capital base changes. Given the French context and the nature of the disclosure (monthly share count), RNS is the most appropriate fallback for a specific regulatory report not covered elsewhere. However, since it is a direct report on the composition of the capital, and 'SHA' is for changes, 'RNS' serves as the best fit for this mandatory periodic capital structure report that isn't a full financial report or a specific transaction announcement.
2024-08-01 French
Inside Information / Other news releases
Earnings Release Classification · 1% confidence The document is explicitly titled as a "PRESS RELEASE" and announces the company's "first-half 2024 sales" with key financial highlights and commentary from the CEO. It provides unaudited figures for the six months ended June 30, 2024. This structure—a brief announcement focusing on key period results (sales figures, growth rates) rather than the comprehensive financial statements found in an Interim Report (IR) or Annual Report (10-K)—is characteristic of an Earnings Release (ER). The document also mentions the upcoming 'Half-year 2024 results' on October 15, 2024, further confirming this is the preliminary sales announcement preceding the full interim report. H1 2024
2024-07-16 English
Informations privilégiées / Autres communiqués
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces the company's "chiffre d'affaires du 1er semestre 2024" (revenue for the first half of 2024). It provides key financial highlights, including revenue figures for the period ending June 30, 2024, and compares them to the previous year. This format—a brief announcement of period-specific financial results—is characteristic of an Earnings Release (ER). It is not the comprehensive Interim/Quarterly Report (IR) itself, as it explicitly states the full results report is scheduled for October 15, 2024 ("Résultats du 1er semestre 2024 : le 15 octobre 2024"). Therefore, it fits the definition of an Earnings Release (ER). H1 2024
2024-07-16 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Earnings Release Classification · 1% confidence The document is titled "Bilan semestriel du Contrat de Liquidité contracté avec TP ICAP" (Semi-annual balance sheet of the Liquidity Contract entered into with TP ICAP) and is dated July 5, 2024. It details the status of the liquidity contract (shares and cash held by the market maker) as of June 28, 2024, and summarizes transactions (purchases and sales) during the first semester of 2024. This type of regular disclosure regarding market making or liquidity provision arrangements is typically filed as a regulatory announcement, often falling under general regulatory reporting or specific market rules. Since it is a periodic report on a specific financial arrangement (liquidity contract) and not a comprehensive financial statement (10-K or IR), nor a management discussion (MDA), nor a dividend notice (DIV), the most appropriate category is a general Regulatory Filing (RNS), as it is a specific, periodic disclosure required by market rules that doesn't fit the other specialized categories. It is not an announcement of a report publication (RPA) because it contains the actual data/balance sheet itself, rather than just announcing that a report is available. H1 2024
2024-07-05 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relating to the Total Number of Shares and Voting Rights Making Up the Share Capital). It explicitly references French regulations (Code de Commerce and AMF general regulation) and provides a monthly update for June 2024 regarding the total number of shares and voting rights. This type of mandatory periodic disclosure concerning the capital structure and voting rights, especially when presented as a brief, standardized monthly update, most closely aligns with a general regulatory filing or a specific capital structure notification. Given the options, it is a specific disclosure about the capital structure, but since there isn't a perfect fit for a 'Monthly Capital Structure Disclosure', I must evaluate the closest options. It is not an ER, 10-K, or IR. It details the composition of the capital, which relates to 'Share Issue/Capital Change' (SHA) or a general 'Regulatory Filing' (RNS). Since it is a routine, periodic disclosure about the current state of shares and voting rights, and not an announcement of a specific transaction (like a buyback or new issue), it fits best as a general regulatory filing (RNS) or potentially a very specific capital structure update. However, looking closely at the definitions, 'SHA' is for 'Announcement regarding new share issues, stock splits, or other capital changes.' This document reports the *current state* of the capital, not a change event. Therefore, 'RNS' (Regulatory Filings - general regulatory announcements and fallback) is the most appropriate category for this standardized, periodic regulatory disclosure that doesn't fit a more specific financial report or transaction type.
2024-07-01 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL" (Monthly information relating to the total number of shares and voting rights comprising the share capital). It explicitly references French commercial code and AMF regulations, and provides a breakdown of the total number of shares and voting rights for the period of 'Mai 2024'. This content directly relates to the structure of the company's capital and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it is a mandatory periodic disclosure regarding the capital structure, even though it is not a direct issuance announcement. It is a formal regulatory disclosure about the current state of the capital base.
2024-06-03 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.